179.26 USD
+4.73
2.71%
At close Updated Nov 26, 1:29 PM EST
1 day
2.71%
5 days
12.93%
1 month
-1.52%
3 months
4.37%
6 months
36.44%
Year to date
-15.69%
1 year
-15.5%
5 years
-6.22%
10 years
138.98%
 

About: Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Employees: 39,800

0
Funds holding %
of 7,475 funds
0
Analysts bullish %
of 6 analysts
0
Positive news %
of 3 articles
Price charts implemented using Lightweight Charts™